Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Bryan Mitton, Katie Hsu, Ritika Dutta, Bruce C. Tiu, Nick Cox, Kevin G. McLure, Hee-Don Chae, Mark Smith, Elizabeth A. Eklund, David E. Solow-Cordero, Kathleen M. Sakamoto
Published Jan 30, 2016 · Vol. 7, No. 8 · pp. 8653-8662
Constantin Lapa, Katharina Lückerath, Martina Rudelius, Jan-Stefan Schmid, Alexander Schoene, Andreas Schirbel, Samuel Samnick, Theo Pelzer, Andreas K. Buck, Saskia Kropf, Hans-Jürgen Wester, Ken Herrmann
Published Jan 28, 2016 · Vol. 7, No. 8 · pp. 9288-9295
Dimitri Topalis, Tatiane C. Nogueira, Tim De Schutter, Chahrazade El Amri, Marcela KreÄmerová, Lieve Naesens, Jan Balzarini, Graciela Andrei, Robert Snoeck
Published Jan 25, 2016 · Vol. 7, No. 9 · pp. 10386-10401